Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 3/2019

01-09-2019 | Original Research

Incidence of Esophageal Cancer in Iran, a Population-Based Study: 2001–2015

Authors: Rahmatollah Moradzadeh, Parvaneh Golmohammadi, Bahman Ghaitasi, Haidar Nadrian, Athareh Najafi

Published in: Journal of Gastrointestinal Cancer | Issue 3/2019

Login to get access

Abstract

Purpose

Even though Kurdistan, the western province of Iran, has a cancer surveillance system, a detailed analysis of incidence rate has not been yet performed. We describe Age Standardized Incidence Rates (ASRs) for esophageal cancer (EC) in Kurdistan Province of Iran in 2001–2015.

Methods

Incidence cases of EC were obtained from a population-based cancer registry. We obtained ASRs and 95% confidence intervals (CI) per 100,000 populations for each calendar year group.

Results

Between 2001 and 2015, 1362 incidence cases with EC were reported to the cancer registry. Annual ASRs in 2006–2010 were more than the other years in both men and women, respectively. Most ASRs were reported among women in Divandarreh (18.95, 95% CI 14.76, 23.92), Saqez (12.75, 95% CI 10.73, 15.01), Sanandaj (8.84, 95% CI 7.64, 10.17), and Qorveh (8.19, 95% CI 6.54, 10.12), and among men in Divandarreh (19.38, 95% CI 15.38, 24.06), Saqez (13.64, 95% CI 11.49, 16.05), Sanandaj (8.70, 95% CI 7.56, 9.96), and Marivan (7.93, 95% CI 6.26, 9.88).

Conclusions

It was concluded that EC in Divandarreh, Saqez, and Sanandaj has the highest ASRs, and these areas are considered as high-risk areas for this disease in the Iranian province of Kurdistan. Therefore, to understand the reasons of these problems, a considerable work is needed.
Literature
2.
go back to reference Global Burden of Disease Cancer C. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–48. https://doi.org/10.1001/jamaoncol.2016.5688.CrossRef Global Burden of Disease Cancer C. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–48. https://​doi.​org/​10.​1001/​jamaoncol.​2016.​5688.CrossRef
6.
go back to reference Naghibzadeh Tahami A, Khanjani N, Yazdi Feyzabadi V, Varzandeh M, Haghdoost A. Opium use as a risk factor for upper gastro-intestinal cancers: a population-based case control study in Iran. Arch Iran Med. 2014;17(1):2–6.PubMed Naghibzadeh Tahami A, Khanjani N, Yazdi Feyzabadi V, Varzandeh M, Haghdoost A. Opium use as a risk factor for upper gastro-intestinal cancers: a population-based case control study in Iran. Arch Iran Med. 2014;17(1):2–6.PubMed
7.
go back to reference Ghasemi-Kebria F, Semnani S, Shakeri R, Khoshnia M, Naeimi-Tabiei M, Merat S, et al. Marked increase in the incidence rate of esophageal adenocarcinoma in a high-risk area for esophageal cancer. Arch Iran Med. 2013;16(6):320–3.PubMed Ghasemi-Kebria F, Semnani S, Shakeri R, Khoshnia M, Naeimi-Tabiei M, Merat S, et al. Marked increase in the incidence rate of esophageal adenocarcinoma in a high-risk area for esophageal cancer. Arch Iran Med. 2013;16(6):320–3.PubMed
8.
go back to reference Haghdoost A, Hosseini H, Chamani G, Zarei M, Rad M, Hashemipoor M, et al. Rising incidence of adenocarcinoma of the esophagus in Kerman, Iran. Arch Iran Med. 2008;11(4):364–70.PubMed Haghdoost A, Hosseini H, Chamani G, Zarei M, Rad M, Hashemipoor M, et al. Rising incidence of adenocarcinoma of the esophagus in Kerman, Iran. Arch Iran Med. 2008;11(4):364–70.PubMed
13.
go back to reference Bray F, Ferlay J. Age standardization. In: Forman D, Bray F, Brewster DH, et al., editors. Cancer Incidence in Five Continents, vol X. Lyon: IARC Scientific Publication No. 164, International Agency for Research on Cancer; 2014. Bray F, Ferlay J. Age standardization. In: Forman D, Bray F, Brewster DH, et al., editors. Cancer Incidence in Five Continents, vol X. Lyon: IARC Scientific Publication No. 164, International Agency for Research on Cancer; 2014.
14.
go back to reference Consonni D, Coviello E, Buzzoni C, Mensi C. A command to calculate age-standardized rates with efficient interval estimation. Stata J. 2012;12(4):688–701.CrossRef Consonni D, Coviello E, Buzzoni C, Mensi C. A command to calculate age-standardized rates with efficient interval estimation. Stata J. 2012;12(4):688–701.CrossRef
18.
go back to reference Mohagheghi M-A, Mosavi-Jarrahi A, Malekzadeh R, Parkin M. Cancer incidence in Tehran Metropolis: the first report from the Tehran population-based cancer registry, 1998–2001. Arch Iran Med. 12(1):15–23. Mohagheghi M-A, Mosavi-Jarrahi A, Malekzadeh R, Parkin M. Cancer incidence in Tehran Metropolis: the first report from the Tehran population-based cancer registry, 1998–2001. Arch Iran Med. 12(1):15–23.
22.
go back to reference Islami F, Pourshams A, Nasrollahzadeh D, Kamangar F, Fahimi S, Shakeri R, et al. Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ: Br Med J. 2009;338 https://doi.org/10.1136/bmj.b929. Islami F, Pourshams A, Nasrollahzadeh D, Kamangar F, Fahimi S, Shakeri R, et al. Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ: Br Med J. 2009;338 https://​doi.​org/​10.​1136/​bmj.​b929.
23.
go back to reference Shakeri R, Malekzadeh R, Etemadi A, Nasrollahzadeh D, Aghcheli K, Sotoudeh M. Opium: an emerging riskfactor for gastric adenocarcinoma. Int J Cancer. 2013;133(2):455–61.CrossRefPubMed Shakeri R, Malekzadeh R, Etemadi A, Nasrollahzadeh D, Aghcheli K, Sotoudeh M. Opium: an emerging riskfactor for gastric adenocarcinoma. Int J Cancer. 2013;133(2):455–61.CrossRefPubMed
24.
go back to reference Fallahzadeh MA, Salehi A, Naghshvarian M, Fallahzadeh MH, Poustchi H, Sepanlou SG, et al. Epidemiologic study of opium use in pars cohort study: a study of 9000 adults in a rural southern area of Iran. Arch Iran Med. 2017;20(4):205–10.PubMed Fallahzadeh MA, Salehi A, Naghshvarian M, Fallahzadeh MH, Poustchi H, Sepanlou SG, et al. Epidemiologic study of opium use in pars cohort study: a study of 9000 adults in a rural southern area of Iran. Arch Iran Med. 2017;20(4):205–10.PubMed
29.
go back to reference Moradzadeh R, Mansournia MA, Baghfalaki T, Ghiasvand R, Noori-Daloii MR, Holakouie-Naieni K. Misclassification adjustment of family history of breast cancer in a case-control study: a Bayesian approach. Asian Pac J Cancer Prev. 2015;16:8221–6.CrossRefPubMed Moradzadeh R, Mansournia MA, Baghfalaki T, Ghiasvand R, Noori-Daloii MR, Holakouie-Naieni K. Misclassification adjustment of family history of breast cancer in a case-control study: a Bayesian approach. Asian Pac J Cancer Prev. 2015;16:8221–6.CrossRefPubMed
Metadata
Title
Incidence of Esophageal Cancer in Iran, a Population-Based Study: 2001–2015
Authors
Rahmatollah Moradzadeh
Parvaneh Golmohammadi
Bahman Ghaitasi
Haidar Nadrian
Athareh Najafi
Publication date
01-09-2019
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 3/2019
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-018-0114-3

Other articles of this Issue 3/2019

Journal of Gastrointestinal Cancer 3/2019 Go to the issue